<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-RB2Y9N96/56168a95-ddf3-4f3f-b58b-f9f14aa21156/PDF"><dcterms:extent>742 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-RB2Y9N96/1ffdb0e3-b65b-48c3-93a3-fe9aba91f817/TEXT"><dcterms:extent>21 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-RB2Y9N96"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>1998</dcterms:issued><dc:creator>Garaj-Vrhovec, Vera</dc:creator><dc:creator>Kopjar, Nevenka</dc:creator><dc:format xml:lang="sl">letnik:32</dc:format><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 385-392</dc:format><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>COBISSID_HOST:8141785</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-RB2Y9N96</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">Adverse effects</dc:subject><dc:subject xml:lang="sl">Antineoplastic agents</dc:subject><dc:subject xml:lang="sl">Lymphocytes</dc:subject><dc:subject xml:lang="sl">Micronucleus tests</dc:subject><dc:subject xml:lang="sl">Occupational exposure</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Micronuclei in cytokinesis-blocked lymphocytes as an index of occupational exposure to antineoplastic drugs| Mikronukleus test pri osebah s poklicno izpostavljenostjo citostatikom|</dc:title><dc:description xml:lang="sl">In order to investigate possible DNA damiging effects of antineoplastic drugs,the micronucleus assay combined with Giemsa, DAPI and silver staining was performed. Blood samples were taken from nurses working without adequate protection in oncological department on preparing and administration of different antineoplastic drugs. Lymphocytes were cultivated in vitro at 37 degrees C. To prevent cytokinesis, at 44th cytochalasine-B at a final concentration of 3 micro g/ml was added. The results obtained indicate statistically significant increases in the total number of micronuclei in the exposed subjects compontrols. DAPI staining has revealed signal-positive and signal-negative miuclei while silver staiing has revealed Ag-NOR+ and Ag-NOR- micronuclei. Compred to controls, the number of signal-positive exposed subjects were increased, indicating a greater susceptibility of particular chromosomes to damage caused by antineopalstic agents</dc:description><dc:description xml:lang="sl">Avtorji so s pomočjo mikronukleus testa v kombinaciji z različnimi tehnikami barvanja (Giemsa, DAPI in srebro) proučevali možne poškodbe DNK zaradi delovanja citostatikov. Krvne vzorce za preiskave so jemali medicinskim sestram, ki so na onkoloških oddelkih brez ustrezne zaščite opravljale delo v zvezi s pripravo in aplikacijo različnih citostatikov. Limfocite so gojili in vitro pri temperaturi 37 degrees C. Za preprečitev citokineze so po 44 urah dodali citohalazin B v končni koncentraciji 3 micro g/ml. Dobljeni rezultati kažejo statistično značilen porast skupnega števila mikronukleusov pri izpostavljeni skupini v primerjavi s kontrolno skupino. Z DAPI tehniko so prikazali signal-pozitivne in signal-negativne mikronukleuse, medtem ko je tehnika bavanja s srebrom razkrila Ag-NOR-pozitivne in Ag-NOR-negativne mikronukleuse. V primerjavi s kontrolno skupino je bilo število signal-pozitivnih in Ag-NOR-pozitivnih nukleusov pri izpostavljenih osebah zvišano, kar kaže, da so nekateri kromosomi bolj dovzetni za poškodbe, ki jih povzročajo citostatiki</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-RB2Y9N96"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-RB2Y9N96" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-RB2Y9N96/56168a95-ddf3-4f3f-b58b-f9f14aa21156/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Onkološki inštitut Ljubljana</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-RB2Y9N96/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-RB2Y9N96" /></ore:Aggregation></rdf:RDF>